Please upgrade to Flash 8 or higher.

References:

  1. Available at Centers for Disease Control and Prevention (CDC): http://www.cdc.gov/nccdphp/dnpa/obesity/index.htm
  2. Available at Centers for Disease Control and Prevention (CDC): http://www.cdc.gov/nccdphp/dnpa/obesity/contributing_factors.htm
  3. Available at National Institute of Health: http://win.niddk.nih.gov/publications/understanding.htm#causes
  4. Available at Science Magazine: http://www.sciencemag.org/cgi/content/abstract/307/5708/375
  5. Available at National Institute of Health: http://win.niddk.nih.gov/publications/understanding.htm#consequences
  6. Available at PubMed: http://www.ncbi.nlm.nih.gov/pubmed/12377306
  7. Available at FDA: http://www.fda.gov/cder/foi/nda/96/018644a_s010_s012_s013.pdf
  8. Available at FDA: http://www.fda.gov/cder/foi/nda/2000/75-434_Naltrexone%20Hydrochloride_Approv.pdf
  9. Available at National Health Institute: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a685041.html
  10. Greenway, F. et al. The Naltrexone-Bupropion Combination Reduces the Prevalence of the Metabolic Syndrome and Improves Cardiometabolic Markers in At-Risk Subjects. Presented at 2008 Obesity Society Meeting.